Investor Astrazeneca Plc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Astrazeneca Plc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-04-10 13G/A 73,892
2025-01-24 13D/A CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 16,000,000 44,000,000
2024-10-28 13G MNPR / Monopar Therapeutics Inc. 387,329
2024-10-11 13G CDT / CDT Equity Inc. 9,504,465
2024-02-12 13G/A ADCT / ADC Therapeutics SA 4,011,215 4,011,215
2023-11-16 13D/A CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 16,000,000 16,000,000
2023-11-09 13D CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) 16,000,000
2023-02-10 13G/A ARDS / Aridis Pharmaceuticals, Inc. 884,956 884,956
2023-02-10 13G/A PIRS / Pieris Pharmaceuticals, Inc. 3,584,230 3,584,230
2021-07-27 13G ARDS / Aridis Pharmaceuticals, Inc. 884,956
2021-04-08 13G PIRS / Pieris Pharmaceuticals, Inc. 3,584,230 3,584,230
2021-04-08 13G PIRS / Pieris Pharmaceuticals, Inc. 3,584,230 3,584,230
2021-02-10 13G/A MRNA / Moderna, Inc. 25,499,325 0
2021-02-10 13G ADCT / ADC Therapeutics SA 4,011,215
2020-02-07 13D MDGN / Medgenics, Inc. 12,946,900
2020-01-30 13G US9266131005 / Viela Bio, Inc. 14,650,334
2019-10-25 13D IPHYF / Innate Pharma S.A. 7,485,500
2019-01-30 13G MRNA / Moderna, Inc. 25,499,325
2018-10-29 13D PHAS / PhaseBio Pharmaceuticals Inc 3,004,554
2018-10-12 13D/A ETTX / Entasis Therapeutics Holdings Inc 2,164,855 2,164,855
2018-10-05 13D ETTX / Entasis Therapeutics Holdings Inc 2,164,855
2018-02-08 13G GTHX / G1 Therapeutics, Inc. 2,950,630
2017-12-11 13D/A ALBO / Albireo Pharma Inc 1,008,141 508,141
2017-02-10 13G ATXS / Astria Therapeutics, Inc. 1,632,652
2016-11-14 13D ALBO / Albireo Pharma Inc 1,008,141
2016-11-14 13D ALBO / Albireo Pharma Inc 1,008,141
2016-02-16 13G RCKT / Rocket Pharmaceuticals, Inc. 1,917,906
2016-02-05 13G/A AGTC / Applied Genetic Technologies Corp
2015-02-17 13G AGTC / Applied Genetic Technologies Corp 1,114,092
2015-01-09 13G/A RGLS / Regulus Therapeutics Inc. 4,250,000
2012-10-12 13G RGLS / Regulus Therapeutics Inc. 6,250,000
2012-06-19 13D/A RDEA / Ardea Biosciences, Inc. 1,000
2012-05-01 13D RDEA / Ardea Biosciences, Inc. 12,181,075